MoneyWorks4Me

Gujarat Themis Biosyn submits analyst meet intimation

14 Feb 2023 Evaluate
Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('the Listing Regulations') read with part A of Schedule III of the Listing Regulations, Gujarat Themis Biosyn has informed that the management of the Company will have a meeting with Analysts/Investors, Taiyo Pacific Partners on Tuesday, 14th February 2023 at Mumbai. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company viz. www.gtbl.in

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..